BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28098757)

  • 1. Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis.
    Bianchi E; Ruberti S; Rontauroli S; Guglielmelli P; Salati S; Rossi C; Zini R; Tagliafico E; Vannucchi AM; Manfredini R
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF.
    Bianchi E; Bulgarelli J; Ruberti S; Rontauroli S; Sacchi G; Norfo R; Pennucci V; Zini R; Salati S; Prudente Z; Ferrari S; Manfredini R
    Cell Death Differ; 2015 Dec; 22(12):1906-21. PubMed ID: 25857263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients.
    Ruberti S; Bianchi E; Guglielmelli P; Rontauroli S; Barbieri G; Tavernari L; Fanelli T; Norfo R; Pennucci V; Fattori GC; Mannarelli C; Bartalucci N; Mora B; Elli L; Avanzini MA; Rossi C; Salmoiraghi S; Zini R; Salati S; Prudente Z; Rosti V; Passamonti F; Rambaldi A; Ferrari S; Tagliafico E; Vannucchi AM; Manfredini R
    Leukemia; 2018 Feb; 32(2):438-449. PubMed ID: 28745329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6.
    Rontauroli S; Norfo R; Pennucci V; Zini R; Ruberti S; Bianchi E; Salati S; Prudente Z; Rossi C; Rosti V; Guglielmelli P; Barosi G; Vannucchi A; Tagliafico E; Manfredini R
    Oncotarget; 2017 Mar; 8(13):21380-21397. PubMed ID: 28423484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis.
    Norfo R; Zini R; Pennucci V; Bianchi E; Salati S; Guglielmelli P; Bogani C; Fanelli T; Mannarelli C; Rosti V; Pietra D; Salmoiraghi S; Bisognin A; Ruberti S; Rontauroli S; Sacchi G; Prudente Z; Barosi G; Cazzola M; Rambaldi A; Bortoluzzi S; Ferrari S; Tagliafico E; Vannucchi AM; Manfredini R;
    Blood; 2014 Sep; 124(13):e21-32. PubMed ID: 25097177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis.
    Rossi C; Zini R; Rontauroli S; Ruberti S; Prudente Z; Barbieri G; Bianchi E; Salati S; Genovese E; Bartalucci N; Guglielmelli P; Tagliafico E; Rosti V; Barosi G; Vannucchi AM; Manfredini R;
    Mol Oncol; 2018 Dec; 12(12):2102-2123. PubMed ID: 30259659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1.
    Zini R; Rossi C; Norfo R; Pennucci V; Barbieri G; Ruberti S; Rontauroli S; Salati S; Bianchi E; Manfredini R
    Stem Cells Dev; 2016 Oct; 25(19):1433-43. PubMed ID: 27520398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.
    Guglielmelli P; Bisognin A; Saccoman C; Mannarelli C; Coppe A; Vannucchi AM; Bortoluzzi S
    PLoS One; 2015; 10(10):e0140445. PubMed ID: 26468945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
    Manshouri T; Verstovsek S; Harris DM; Veletic I; Zhang X; Post SM; Bueso-Ramos CE; Estrov Z
    PLoS One; 2019; 14(9):e0222912. PubMed ID: 31569199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19
    Qu M; Fang F; Zou X; Zeng Q; Fan Z; Chen L; Yue W; Xie X; Pei X
    Cell Death Dis; 2016 Oct; 7(10):e2430. PubMed ID: 27763644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
    Wang X; Haylock D; Hu CS; Kowalczyk W; Jiang T; Qiu J; Mosoyan G; He W; Marshall N; Mascarenhas J; Tarasova A; Brody J; Winkler D; Hoffman R
    Blood; 2016 Jun; 127(26):3398-409. PubMed ID: 27114459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin A type 1B receptor gene and finally reducing C/EBPα expression.
    Lin HS; Gong JN; Su R; Chen MT; Song L; Shen C; Wang F; Ma YN; Zhao HL; Yu J; Li WW; Huang LX; Xu XH; Zhang JW
    J Leukoc Biol; 2014 Dec; 96(6):1023-35. PubMed ID: 25258381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis.
    Desterke C; Bilhou-Nabéra C; Guerton B; Martinaud C; Tonetti C; Clay D; Guglielmelli P; Vannucchi A; Bordessoule D; Hasselbalch H; Dupriez B; Benzoubir N; Bourgeade MF; Pierre-Louis O; Lazar V; Vainchenker W; Bennaceur-Griscelli A; Gisslinger H; Giraudier S; Le Bousse-Kerdilès MC; ; ;
    Cancer Res; 2011 Apr; 71(8):2901-15. PubMed ID: 21487043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophages.
    Rodriguez-Ubreva J; Ciudad L; van Oevelen C; Parra M; Graf T; Ballestar E
    Mol Cell Biol; 2014 Mar; 34(6):1145-57. PubMed ID: 24421386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.
    Navarro F; Gutman D; Meire E; Cáceres M; Rigoutsos I; Bentwich Z; Lieberman J
    Blood; 2009 Sep; 114(10):2181-92. PubMed ID: 19584398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.
    Wang X; Zhang W; Tripodi J; Lu M; Xu M; Najfeld V; Li Y; Hoffman R
    Blood; 2010 Dec; 116(26):5972-82. PubMed ID: 20858855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells.
    Calura E; Pizzini S; Bisognin A; Coppe A; Sales G; Gaffo E; Fanelli T; Mannarelli C; Zini R; Norfo R; Pennucci V; Manfredini R; Romualdi C; Guglielmelli P; Vannucchi AM; Bortoluzzi S
    Blood Cancer J; 2016 Jun; 6(6):e439. PubMed ID: 27341078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
    Liang J; Li Y; Daniels G; Sfanos K; De Marzo A; Wei J; Li X; Chen W; Wang J; Zhong X; Melamed J; Zhao J; Lee P
    Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-34a-5p promotes autophagy and apoptosis of ovarian granulosa cells via the Hippo-YAP signaling pathway by targeting LEF1 in chicken.
    Han S; Zhao X; Zhang Y; Amevor FK; Tan B; Ma M; Kang H; Wang J; Zhu Q; Yin H; Cui C
    Poult Sci; 2023 Feb; 102(2):102374. PubMed ID: 36529101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.